Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Neil Skolnik, Renell S. Dupree & Eric L. Johnson. (2017) iGlarLixi, a titratable once-daily fixed-ratio combination of basal insulin and lixisenatide for intensifying type 2 diabetes management for patients inadequately controlled on basal insulin with or without oral agents. Current Medical Research and Opinion 33:12, pages 2187-2194.
Read now
Read now
Articles from other publishers (16)
Ashenafi Kibret Sendekie, Eyayaw Ashete Belachew, Ephrem Mebratu Dagnew & Adeladlew Kassie Netere. (2022) Rate of glycaemic control and associated factors in patients with type 2 diabetes mellitus treated with insulin-based therapy at selected hospitals in Northwest Ethiopia: a multicentre cross-sectional study. BMJ Open 12:9, pages e065250.
Crossref
Crossref
Devin Steenkamp, Elizabeth L Eby, Nany Gulati & Birong Liao. (2021) Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem. Journal of Diabetes Science and Technology 16:4, pages 995-1002.
Crossref
Crossref
Elizabeth L. Eby, Neal R. Kelly, Jeffrey K. Hertzberg, Moira C. Blodgett, Callie Stubbins, Raja H. Patel, Eric S Meadows, Brian D. Benneyworth & Douglas E. Faries. (2022) Predicting Response to Bolus Insulin Therapy in Patients With Type 2 Diabetes. Journal of Diabetes Science and Technology, pages 193229682210980.
Crossref
Crossref
A. Enrique Caballero, Beth L. Nordstrom, Birong Liao, Ludi Fan, Nan Zhang, Kathy H. Fraeman & Magaly Perez-Nieves. (2021) Individualized HbA1c target selection and achievement in the Multinational Observational Study Assessing Insulin Use (MOSA1c) type 2 diabetes study. Journal of Diabetes and its Complications 35:11, pages 108011.
Crossref
Crossref
David A. Price, Qianqian Deng, Mark Kipnes & Stayce E. Beck. (2021) Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial. Diabetes Therapy 12:7, pages 2089-2099.
Crossref
Crossref
Luigi F. Meneghini, Didac Mauricio, Emanuela Orsi, Nebojsa M. Lalic, Anna M.G. Cali, Jukka Westerbacka, Peter Stella, Christophe Candelas, DEA, Valerie Pilorget, Riccardo Perfetti & Kamlesh Khunti. (2019) The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting. Diabetes, Obesity and Metabolism 21:6, pages 1429-1436.
Crossref
Crossref
Lori Berard, Mireille Bonnemaire, Marie Mical & Steve Edelman. (2017)
Insights into optimal basal insulin titration in type 2 diabetes:
R
esults of a quantitative survey
. Diabetes, Obesity and Metabolism 20:2, pages 301-308.
Crossref
Crossref
Inna V. Misnikova, Valeria A. Gubkina, Tatyana S. Lakeeva & Alexander V. Dreval. (2017) A Randomized Controlled Trial to Assess the Impact of Proper Insulin Injection Technique Training on Glycemic Control. Diabetes Therapy 8:6, pages 1309-1318.
Crossref
Crossref
Dídac Mauricio, Luigi Meneghini, Jochen Seufert, Laura Liao, Hongwei Wang, Liyue Tong, Anna Cali, Peter Stella, Paulo Carita & Kamlesh Khunti. (2017) Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA. Diabetes, Obesity and Metabolism 19:8, pages 1155-1164.
Crossref
Crossref
J.G. Kuiper, E.M. Heintjes, F.J.A. Penning-van Beest & R.M.C. Herings. (2017) Glykemische controle met basale insuline in vergelijking met DPP-4-remmers. Nederlands Tijdschrift voor Diabetologie 15:1, pages 5-10.
Crossref
Crossref
M. Baxter, R. Hudson, J. Mahon, C. Bartlett, Y. Samyshkin, D. Alexiou & N. Hex. (2016) Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit. Diabetic Medicine 33:11, pages 1575-1581.
Crossref
Crossref
Mehul R. Dalal, Michael Grabner, Nicole Bonine, Judith J. Stephenson, Andres DiGenio & Nella Bieszk. (2016) Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets. Diabetes Research and Clinical Practice 121, pages 17-26.
Crossref
Crossref
Harpreet S. BajajKarri VennChenglin YeRonnie Aronson. (2016) Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE Trial). Diabetes Technology & Therapeutics 18:10, pages 610-615.
Crossref
Crossref
J. Mancera-Romero, F. Carramiñana-Barrera, L. Muñoz-González, P. Guillén-Álvarez, D. Murillo-García & M.R. Sánchez-Pérez. (2016) Satisfacción de las personas con diabetes mellitus tipo 2 tras iniciar tratamiento con insulina. SEMERGEN - Medicina de Familia 42:5, pages 298-306.
Crossref
Crossref
A.-J. Scheen. (2016) Instauration d’une insulinothérapie chez le patient diabétique de type 2 en médecine générale : Comparaison de l’étude belge InsuStar avec quelques études françaises et internationales. Médecine des Maladies Métaboliques 10:4, pages 334-340.
Crossref
Crossref
S. Halimi. (2015) Perspectives pour améliorer la prise en charge des patients diabétiques de type 2 sous insuline. Médecine des Maladies Métaboliques 9:3, pages 3S34-3S42.
Crossref
Crossref